Guilin Sanjin Pharmaceutical Co Ltd
SZSE:002275
Income Statement
Earnings Waterfall
Guilin Sanjin Pharmaceutical Co Ltd
Revenue
|
1.9B
CNY
|
Cost of Revenue
|
-564.3m
CNY
|
Gross Profit
|
1.4B
CNY
|
Operating Expenses
|
-974.7m
CNY
|
Operating Income
|
399.3m
CNY
|
Other Expenses
|
-47.2m
CNY
|
Net Income
|
352.1m
CNY
|
Income Statement
Guilin Sanjin Pharmaceutical Co Ltd
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1 429
N/A
|
1 458
+2%
|
1 423
-2%
|
1 466
+3%
|
1 343
-8%
|
1 394
+4%
|
1 352
-3%
|
1 391
+3%
|
1 470
+6%
|
1 448
-2%
|
1 495
+3%
|
1 525
+2%
|
1 559
+2%
|
1 582
+2%
|
1 600
+1%
|
1 616
+1%
|
1 626
+1%
|
1 643
+1%
|
1 649
+0%
|
1 585
-4%
|
1 617
+2%
|
1 619
+0%
|
1 600
-1%
|
1 640
+3%
|
1 592
-3%
|
1 602
+1%
|
1 611
+1%
|
1 567
-3%
|
1 667
+6%
|
1 694
+2%
|
1 724
+2%
|
1 741
+1%
|
1 829
+5%
|
1 857
+2%
|
1 925
+4%
|
1 960
+2%
|
2 159
+10%
|
2 158
0%
|
2 153
0%
|
2 172
+1%
|
1 938
-11%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(428)
|
(414)
|
(398)
|
(415)
|
(365)
|
(386)
|
(386)
|
(385)
|
(431)
|
(436)
|
(439)
|
(410)
|
(445)
|
(452)
|
(453)
|
(390)
|
(428)
|
(423)
|
(442)
|
(433)
|
(474)
|
(483)
|
(472)
|
(446)
|
(485)
|
(473)
|
(475)
|
(449)
|
(498)
|
(542)
|
(542)
|
(457)
|
(481)
|
(489)
|
(512)
|
(574)
|
(658)
|
(647)
|
(639)
|
(603)
|
(564)
|
|
Gross Profit |
1 000
N/A
|
1 044
+4%
|
1 025
-2%
|
1 051
+3%
|
978
-7%
|
1 008
+3%
|
967
-4%
|
1 006
+4%
|
1 039
+3%
|
1 011
-3%
|
1 056
+4%
|
1 115
+6%
|
1 114
0%
|
1 131
+1%
|
1 147
+1%
|
1 226
+7%
|
1 198
-2%
|
1 220
+2%
|
1 207
-1%
|
1 152
-5%
|
1 143
-1%
|
1 136
-1%
|
1 128
-1%
|
1 195
+6%
|
1 107
-7%
|
1 129
+2%
|
1 136
+1%
|
1 117
-2%
|
1 169
+5%
|
1 153
-1%
|
1 182
+3%
|
1 284
+9%
|
1 347
+5%
|
1 367
+2%
|
1 412
+3%
|
1 385
-2%
|
1 501
+8%
|
1 511
+1%
|
1 514
+0%
|
1 569
+4%
|
1 374
-12%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(538)
|
(555)
|
(557)
|
(560)
|
(506)
|
(545)
|
(515)
|
(607)
|
(616)
|
(603)
|
(622)
|
(670)
|
(653)
|
(645)
|
(654)
|
(689)
|
(655)
|
(671)
|
(651)
|
(656)
|
(634)
|
(616)
|
(647)
|
(730)
|
(653)
|
(709)
|
(717)
|
(779)
|
(809)
|
(825)
|
(862)
|
(894)
|
(900)
|
(894)
|
(958)
|
(987)
|
(1 040)
|
(1 027)
|
(1 034)
|
(1 070)
|
(975)
|
|
Selling, General & Administrative |
(543)
|
(558)
|
(563)
|
(540)
|
(501)
|
(539)
|
(509)
|
(551)
|
(615)
|
(600)
|
(618)
|
(608)
|
(652)
|
(634)
|
(621)
|
(628)
|
(613)
|
(614)
|
(602)
|
(590)
|
(572)
|
(561)
|
(596)
|
(629)
|
(566)
|
(608)
|
(588)
|
(631)
|
(641)
|
(656)
|
(711)
|
(739)
|
(764)
|
(777)
|
(821)
|
(824)
|
(897)
|
(902)
|
(912)
|
(934)
|
(887)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(32)
|
0
|
0
|
0
|
(38)
|
0
|
0
|
(21)
|
(54)
|
0
|
0
|
(34)
|
(56)
|
(53)
|
(77)
|
(74)
|
(92)
|
(114)
|
(126)
|
(157)
|
(141)
|
(189)
|
(194)
|
(214)
|
(183)
|
(210)
|
(176)
|
(160)
|
(194)
|
(220)
|
0
|
(204)
|
(135)
|
(127)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
(36)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
(36)
|
0
|
0
|
0
|
(52)
|
0
|
0
|
0
|
(47)
|
0
|
|
Other Operating Expenses |
5
|
3
|
6
|
(2)
|
(5)
|
(6)
|
(7)
|
(3)
|
(1)
|
(4)
|
(4)
|
(5)
|
(1)
|
(11)
|
(11)
|
14
|
(42)
|
(57)
|
(15)
|
19
|
(9)
|
23
|
23
|
27
|
27
|
25
|
28
|
25
|
20
|
25
|
63
|
64
|
74
|
59
|
23
|
83
|
77
|
(125)
|
82
|
46
|
40
|
|
Operating Income |
462
N/A
|
489
+6%
|
468
-4%
|
491
+5%
|
472
-4%
|
463
-2%
|
452
-2%
|
399
-12%
|
424
+6%
|
408
-4%
|
433
+6%
|
445
+3%
|
461
+4%
|
486
+5%
|
493
+1%
|
537
+9%
|
542
+1%
|
549
+1%
|
555
+1%
|
496
-11%
|
509
+3%
|
520
+2%
|
481
-8%
|
465
-3%
|
454
-2%
|
420
-7%
|
420
0%
|
338
-19%
|
360
+6%
|
327
-9%
|
320
-2%
|
390
+22%
|
447
+15%
|
474
+6%
|
454
-4%
|
399
-12%
|
460
+16%
|
484
+5%
|
480
-1%
|
499
+4%
|
399
-20%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
26
|
24
|
27
|
31
|
24
|
30
|
26
|
25
|
26
|
21
|
20
|
23
|
16
|
17
|
21
|
27
|
31
|
35
|
30
|
2
|
(6)
|
(17)
|
(23)
|
3
|
1
|
9
|
22
|
17
|
20
|
21
|
14
|
24
|
15
|
21
|
13
|
17
|
18
|
9
|
17
|
18
|
24
|
|
Non-Reccuring Items |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
1
|
(1)
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
(2)
|
0
|
16
|
16
|
15
|
0
|
(1)
|
(0)
|
30
|
30
|
29
|
29
|
2
|
8
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
30
|
29
|
28
|
8
|
7
|
7
|
6
|
17
|
20
|
21
|
22
|
13
|
8
|
6
|
7
|
(1)
|
(1)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(1)
|
(2)
|
(4)
|
(3)
|
(9)
|
(10)
|
(7)
|
(7)
|
(0)
|
0
|
(0)
|
(3)
|
0
|
(1)
|
(1)
|
2
|
0
|
(0)
|
|
Pre-Tax Income |
518
N/A
|
542
+5%
|
523
-3%
|
531
+1%
|
502
-5%
|
500
0%
|
483
-3%
|
440
-9%
|
469
+6%
|
449
-4%
|
476
+6%
|
480
+1%
|
485
+1%
|
509
+5%
|
521
+2%
|
563
+8%
|
572
+2%
|
583
+2%
|
584
+0%
|
496
-15%
|
501
+1%
|
501
+0%
|
456
-9%
|
468
+2%
|
454
-3%
|
427
-6%
|
438
+3%
|
344
-21%
|
370
+7%
|
357
-3%
|
342
-4%
|
429
+25%
|
462
+8%
|
494
+7%
|
464
-6%
|
446
-4%
|
507
+14%
|
521
+3%
|
528
+1%
|
518
-2%
|
431
-17%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(94)
|
(94)
|
(90)
|
(86)
|
(80)
|
(79)
|
(78)
|
(64)
|
(71)
|
(65)
|
(69)
|
(86)
|
(86)
|
(90)
|
(95)
|
(99)
|
(100)
|
(101)
|
(101)
|
(82)
|
(83)
|
(83)
|
(79)
|
(76)
|
(73)
|
(68)
|
(72)
|
(67)
|
(72)
|
(74)
|
(78)
|
(85)
|
(96)
|
(95)
|
(88)
|
(117)
|
(129)
|
(115)
|
(126)
|
(97)
|
(79)
|
|
Income from Continuing Operations |
424
|
449
|
434
|
445
|
422
|
421
|
405
|
377
|
398
|
384
|
407
|
394
|
399
|
419
|
426
|
464
|
472
|
482
|
483
|
413
|
418
|
418
|
377
|
392
|
381
|
359
|
367
|
277
|
298
|
283
|
265
|
344
|
366
|
399
|
375
|
330
|
379
|
406
|
402
|
421
|
352
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
424
N/A
|
449
+6%
|
434
-3%
|
445
+3%
|
422
-5%
|
421
0%
|
405
-4%
|
377
-7%
|
398
+6%
|
384
-3%
|
407
+6%
|
394
-3%
|
399
+1%
|
419
+5%
|
426
+2%
|
464
+9%
|
472
+2%
|
482
+2%
|
483
+0%
|
413
-14%
|
418
+1%
|
418
+0%
|
377
-10%
|
392
+4%
|
381
-3%
|
359
-6%
|
367
+2%
|
277
-24%
|
298
+8%
|
283
-5%
|
265
-6%
|
344
+30%
|
366
+7%
|
399
+9%
|
375
-6%
|
330
-12%
|
379
+15%
|
406
+7%
|
402
-1%
|
421
+5%
|
352
-16%
|
|
EPS (Diluted) |
0.71
N/A
|
0.75
+6%
|
0.73
-3%
|
0.75
+3%
|
0.72
-4%
|
0.72
N/A
|
0.69
-4%
|
0.64
-7%
|
0.67
+5%
|
0.64
-4%
|
0.68
+6%
|
0.67
-1%
|
0.67
N/A
|
0.71
+6%
|
0.72
+1%
|
0.79
+10%
|
0.8
+1%
|
0.82
+2%
|
0.82
N/A
|
0.7
-15%
|
0.71
+1%
|
0.71
N/A
|
1
+41%
|
0.68
-32%
|
0.66
-3%
|
0.62
-6%
|
0.68
+10%
|
0.48
-29%
|
0.5
+4%
|
0.5
N/A
|
0.46
-8%
|
0.6
+30%
|
0.64
+7%
|
0.7
+9%
|
0.61
-13%
|
0.56
-8%
|
0.65
+16%
|
0.69
+6%
|
0.69
N/A
|
0.72
+4%
|
0.6
-17%
|